{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:38:21Z","timestamp":1777444701720,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1006\/taap.2001.9303","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:46:05Z","timestamp":1033933565000},"page":"238-246","source":"Crossref","is-referenced-by-count":54,"title":["Arsenic-Induced Congenital Malformations in Genetically Susceptible Folate Binding Protein-2 Knockout Mice"],"prefix":"10.1006","volume":"177","author":[{"given":"Bogdan","family":"Wlodarczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Spiegelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan\u00e9e","family":"Gelineau-van Waes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseann L.","family":"Vorce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris X.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Finnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/taap.2001.9303_RF1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1096-9926(200007)62:1<42::AID-TERA9>3.0.CO;2-U","article-title":"Hypothesis: Folate-responsive neural tube defects and neurocristopathies","volume":"62","author":"Antony","year":"2000","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.pharmtox.37.1.397","article-title":"Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity","volume":"37","author":"Aposhian","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/tx000114o","article-title":"Occurrence of monomethylarsonous acid (MMAIII) in urine of humans exposed to inorganic arsenic","volume":"13","author":"Aposhian","year":"2000","journal-title":"Chem. Res. Toxicol"},{"key":"10.1006\/taap.2001.9303_RF4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/mgme.1998.2772","article-title":"Expression patterns of folate binding proteins one and two in the developing mouse embryo","volume":"66","author":"Barber","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1006\/taap.2001.9303_RF5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","article-title":"Neural-tube defects","volume":"341","author":"Botto","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/taap.2001.9303_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/toxsci\/44.2.185","article-title":"Exposure to inorganic arsenic metabolites during early human development","volume":"44","author":"Concha","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1006\/taap.2001.9303_RF7","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/taap.2001.9303_RF8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000134104","article-title":"Molecular and cytological evidense of S-adenosyl-l-homocysteine as an innocuous undermethylating agent in vivo","volume":"71","author":"De Cabo","year":"1995","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1006\/taap.2001.9303_RF9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/tera.1060","article-title":"Teratogen update: Inorganic arsenic","volume":"63","author":"DeSesso","year":"2001","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0890-6238(98)00021-5","article-title":"An assessment of the developmental toxicity of inorganic arsenic","volume":"12","author":"DeSesso","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9378(31)90842-9","article-title":"The arsenic content of the human placenta following arsphenamine therapy","volume":"21","author":"Eastman","year":"1931","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1006\/taap.2001.9303_RF12","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1016\/S0021-9258(18)63786-X","article-title":"Molecular cloning and characterization of the human folate binding protein cDNA from placenta and malignant tissue culture","volume":"264","author":"Elwood","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1006\/taap.2001.9303_RF13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0028-2243(94)90225-9","article-title":"Primary prevention of neural-tube defects with folic acid","volume":"53","author":"Eskes","year":"1994","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1006\/taap.2001.9303_RF14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1749-6632.2000.tb06886.x","article-title":"Genetic basis of susceptibility to environmentally induced neural tube defects","volume":"919","author":"Finnell","year":"2000","journal-title":"Ann. NY Acad. Sci"},{"key":"10.1006\/taap.2001.9303_RF15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10937409809524552","article-title":"Developmental and reproductive toxicity of inorganic arsenic: Animal studies and human concerns","volume":"1","author":"Golub","year":"1998","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1006\/taap.2001.9303_RF16","article-title":"Unstable trivalent arsenic metabolites; monomethylarsonous acid and dimethylarsinous acid","volume":"16","author":"Gong","year":"2001","journal-title":"J. Anal. Atom. Spectrum."},{"key":"10.1006\/taap.2001.9303_RF17","first-page":"385","article-title":"Modulation of folate receptor expression in vitro by antisense oligonucleotides produces neural tube defects in mouse embryos","volume":"59","author":"Hansen","year":"1999","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jn\/122.4.888","article-title":"Folate deficiency alone does not produce neural tube defects in mice","volume":"122","author":"Heid","year":"1992","journal-title":"J. Nutr."},{"key":"10.1006\/taap.2001.9303_RF19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1096-9926(200007)62:1<51::AID-TERA10>3.0.CO;2-T","article-title":"Appropriate use of animal models in the assessment of risk during prenatal development: An illustration using inorganic arsenic","volume":"62","author":"Holson","year":"2000","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/tera.1420350104","article-title":"Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration","volume":"35","author":"Hood","year":"1987","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0300-483X(99)00068-2","article-title":"Strain-dependent disposition of inorganic arsenic in the mouse","volume":"137","author":"Hughes","year":"1999","journal-title":"Toxicology"},{"key":"10.1006\/taap.2001.9303_RF22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jn\/124.7.1072","article-title":"Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction","volume":"124","author":"Jacob","year":"1994","journal-title":"J. Nutr."},{"key":"10.1006\/taap.2001.9303_RF23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/014107689308600515","article-title":"A history of the use of arsenicals in man","volume":"86","author":"Jolliffe","year":"1993","journal-title":"J. R. Soc. Med."},{"key":"10.1006\/taap.2001.9303_RF24","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/ac000527u","article-title":"Speciation of key arsenic metabolic intermediates in human urine","volume":"72","author":"Le","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1006\/taap.2001.9303_RF25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1289\/ehp.001081015","article-title":"Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine","volume":"108","author":"Le","year":"2000","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.2001.9303_RF26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/tx9900775","article-title":"Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase","volume":"12","author":"Lin","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/tx0001878","article-title":"Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes","volume":"14","author":"Lin","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/tx000246h","article-title":"Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India","volume":"14","author":"Mandal","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0009-2797(84)90131-5","article-title":"The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits","volume":"50","author":"Marafante","year":"1984","journal-title":"Chem.\u2013Biol. Interact."},{"key":"10.1006\/taap.2001.9303_RF30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/tx000251l","article-title":"Methylated trivalent arsenic species are genotoxic","volume":"14","author":"Mass","year":"2001","journal-title":"Chem. Res. Toxicol"},{"key":"10.1006\/taap.2001.9303_RF31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(95)90165-5","article-title":"Homocysteine metabolism in pregnancies complicated by neural-tube defects","volume":"345","author":"Mills","year":"1995","journal-title":"Lancet"},{"key":"10.1006\/taap.2001.9303_RF32","first-page":"756S","article-title":"Homocysteine and neural tube defects","volume":"126","author":"Mills","year":"1996","journal-title":"J. Nutr."},{"key":"10.1006\/taap.2001.9303_RF33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-9120(96)00172-5","article-title":"Clinical chemistry and molecular biology of homocysteine metabolism: An update","volume":"30","author":"Miner","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1006\/taap.2001.9303_RF34","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1001\/jama.1988.03410210053035","article-title":"Periconceptional use of multivitamins and the occurrence of neural tube defects","volume":"260","author":"Mulinare","year":"1988","journal-title":"J. Am. Med. Assoc."},{"key":"10.1006\/taap.2001.9303_RF35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/taap.1999.8872","article-title":"Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes","volume":"163","author":"Petrick","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/taap.2001.9303_RF36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/tx000264z","article-title":"Methylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase","volume":"14","author":"Petrick","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/13861","article-title":"Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development","volume":"23","author":"Piedrahita","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1006\/taap.2001.9303_RF38","first-page":"165","article-title":"Pharmacokinetics, metabolism and carcinogenicity of arsenic","volume":"169","author":"Pott","year":"2001","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF39","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/bi00446a042","article-title":"Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA","volume":"28","author":"Ratnam","year":"1989","journal-title":"Biochemistry"},{"key":"10.1006\/taap.2001.9303_RF40","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1073\/pnas.93.26.15227","article-title":"Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid","volume":"93","author":"Rosenquist","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/taap.2001.9303_RF41","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"key":"10.1006\/taap.2001.9303_RF42","first-page":"171","article-title":"Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid","volume":"19","author":"Rozen","year":"1996","journal-title":"Clin. Invest. Med."},{"key":"10.1006\/taap.2001.9303_RF43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.nu.10.070190.001425","article-title":"The role of nutrition in neural tube defects","volume":"10","author":"Scott","year":"1990","journal-title":"Annu. Rev. Nutr."},{"key":"10.1006\/taap.2001.9303_RF44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/009841096161320","article-title":"Role of arsenic as a reproductive toxin with particular attention to neural tube defects","volume":"48","author":"Shalat","year":"1996","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1006\/taap.2001.9303_RF45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/tera.1420490210","article-title":"Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983\u20131987","volume":"49","author":"Shaw","year":"1994","journal-title":"Teratology"},{"key":"10.1006\/taap.2001.9303_RF46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(95)92778-6","article-title":"Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally","volume":"346","author":"Shaw","year":"1995","journal-title":"Lancet"},{"key":"10.1006\/taap.2001.9303_RF47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/bi00171a021","article-title":"Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: CDNA cloning, expression, immunoreactivity, and tissue specificity","volume":"8","author":"Shen","year":"1994","journal-title":"Biochemistry"},{"key":"10.1006\/taap.2001.9303_RF48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1289\/ehp.9297259","article-title":"Cancer risks from arsenic in drinking water","volume":"97","author":"Smith","year":"1992","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/taap.2001.9303_RF49","first-page":"30","article-title":"The relation of mating, ovulation, and the estrus smear in the house mouse to the time of day","volume":"76","author":"Snell","year":"1948","journal-title":"Anat. Rec."},{"key":"10.1006\/taap.2001.9303_RF50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-1119(00)00418-2","article-title":"Identification of two putative novel folate receptor genes in humans and mouse","volume":"27","author":"Spiegelstein","year":"2000","journal-title":"Gene"},{"key":"10.1006\/taap.2001.9303_RF51","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/0002-9378(95)90474-3","article-title":"Neural tube defects and elevated homocysteine levels in amniotic fluid","volume":"172","author":"Steegers-Theunissen","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1006\/taap.2001.9303_RF52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJM199101173240315","article-title":"Neural-tube defects and derangement of homocysteine metabolism","volume":"324","author":"Steegers-Theunissen","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/taap.2001.9303_RF53","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0026-0495(94)90004-3","article-title":"Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?","volume":"43","author":"Steegers-Theunissen","year":"1994","journal-title":"Metabolism"},{"key":"10.1006\/taap.2001.9303_RF54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0009-2797(95)03666-0","article-title":"Mono- and dimethylation of arsenic in rat liver cytosol in vitro","volume":"99","author":"Styblo","year":"1996","journal-title":"Chem.\u2013Biol. Interact."},{"key":"10.1006\/taap.2001.9303_RF55","series-title":"Arsenic Exposure and Health Effects","first-page":"325","article-title":"Trivalent methylated arsenicals: Toxic products of the metabolism of inorganic arsenic","author":"Styblo","year":"2001"},{"key":"10.1006\/taap.2001.9303_RF56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/tx960139g","article-title":"Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols","volume":"10","author":"Styblo","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1006\/taap.2001.9303_RF57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0300-483X(95)03111-R","article-title":"An attempt to explain the interindividual variability in 24-h urinary excretion of inorganic arsenic metabolites by C57 BL\/6J mice","volume":"103","author":"Telolahy","year":"1995","journal-title":"Toxicology"},{"key":"10.1006\/taap.2001.9303_RF58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-4274(99)00271-4","article-title":"Genetic polymorphisms in the biotransformation of inorganic arsenic and its role in toxicity","volume":"112\u2013113","author":"Vahter","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1006\/taap.2001.9303_RF59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0013-9351(83)90187-1","article-title":"In vivo reduction of arsenate in mice and rabbits","volume":"32","author":"Vahter","year":"1983","journal-title":"Environ. Res."},{"key":"10.1006\/taap.2001.9303_RF60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0378-4274(87)90165-2","article-title":"Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit","volume":"37","author":"Vahter","year":"1987","journal-title":"Toxicol. Lett."},{"key":"10.1006\/taap.2001.9303_RF61","series-title":"The Biological Alkylation of Heavy Elements","first-page":"105","article-title":"In vivo methylation and detoxification of arsenic","author":"Vahter","year":"1988"},{"key":"10.1006\/taap.2001.9303_RF62","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/0006-2952(92)90089-2","article-title":"Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates","volume":"44","author":"Wang","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/taap.2001.9303_RF63","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.1993.03500100055027","article-title":"Periconceptional folic acid exposure and risk of occurrent neural tube defects","volume":"269","author":"Werler","year":"1993","journal-title":"J. Am. Med. Assoc."},{"key":"10.1006\/taap.2001.9303_RF64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/faat.1995.1052","article-title":"Health risks associated with prenatal metal exposure","volume":"25","author":"Zelikoff","year":"1995","journal-title":"Fundam. Appl. Toxicol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X01993032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X01993032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:10:47Z","timestamp":1682284247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X01993032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0041008X01993032"],"URL":"https:\/\/doi.org\/10.1006\/taap.2001.9303","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}